Kirsten Schmidt-Hellerau, Nina Baade, Marina Günther, Nadine Scholten, Christoph Heinrich Lindemann, Charlotte Leisse, Charlotte Oberröhrmann, Sophie Peter, Norma Jung, Isabelle Suarez, Carola Horn, Peter Ihle, Jutta Küpper-Nybelen, Anna Hagemeier, Martin Hellmich, Clara Lehmann
PURPOSE: Outpatient parenteral antimicrobial therapy (OPAT) offers several key advantages, including enhanced patient quality of life, reduced healthcare costs, and a potential reduction of nosocomial infections. It is acknowledged for its safety and effectiveness. This study provides the first systematic clinical data for Germany, where OPAT has not yet been widely adopted. The aim is to establish a foundational reference point for further research and integration of OPAT into the German healthcare system...
March 13, 2024: Infection